Holen Sie sich die Stockscreener-App
43.51
3.10%
1.31
Handel nachbörslich:
43.51
Finanzdaten der Kymera Therapeutics Inc-Aktie (KYMR)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
48.07%
11.48
|
22.10 | 7.394 | 3.741 | 25.65 |
| Cost Of Revenue |
48.07%
11.48
|
22.10 | - | - | - |
| Gross Profit |
-
|
- | - | - | - |
Operating Expenses
|
0.51%
96.03
|
96.53 | 88.15 | 75.86 | 76.58 |
| Benefits Costs and Expenses |
100.00%
-
|
87.68 | 78.15 | - | - |
| Costs And Expenses |
9.53%
96.03
|
87.68 | 78.15 | 75.86 | 76.58 |
| Operating Income/Loss |
13.61%
-84.56
|
-74.43 | -80.75 | -72.12 | -50.92 |
| Income/Loss From Continuing Operations Before Tax |
117.50%
11.48
|
-65.58 | -70.75 | 3.741 | 25.65 |
| Income/Loss From Continuing Operations After Tax |
16.82%
-76.61
|
-65.58 | -70.75 | -62.49 | -42.06 |
|
Net Income/Loss
|
16.82%
-76.61
|
-65.58 | -70.75 | -62.49 | -42.06 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.38%
80.45
|
80.15 | 1.7137 | 76.13 | 73.06 |
| Diluted Average Shares |
0.38%
80.45
|
80.15 | 1.7137 | 76.13 | 73.06 |
| Basic Earnings Per Share |
15.85%
-0.95
|
-0.82 | -0.89 | -0.82 | -0.58 |
| Diluted Earnings Per Share |
15.85%
-0.95
|
-0.82 | -0.89 | -0.82 | -0.58 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):